Endometrial Cancer Trial, Recruiting (NCT05727228)

Endometrial Cancer Trial, Recruiting NCT05727228 Sponsor: University of Aarhus Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05727228 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 50–64 who have tested positive for HPV through a screening program
Women aged 23–64 who are having a follow-up test (HPV and cell sample) six months after a LEEP procedure (a treatment to remove abnormal cells from the cervix) in the Central Denmark Region
Women aged 23–64 who are having a follow-up test (HPV and cell sample) 12 months after a LEEP procedure
Women aged 23–64 who have a valid cell sample (cytology) triage result on record

Who may not be able to join:

People who are recorded in the registry as having previously declined to take part in research
Women whose cell sample and HPV test results from six months after their LEEP procedure were not usable or were incomplete
Cases where there is no remaining biological sample material available for testing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: mette tranberg, post doc, Randers Regional Hospital, Denmark

Phone: 40113676

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05727228

Sponsor: University of Aarhus

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 40113676

More information: https://clinicaltrials.gov/study/NCT05727228

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 50–64 who have tested positive for HPV through a screening program
Women aged 23–64 who are having a follow-up test (HPV and cell sample) six months after a LEEP procedure (a treatment to remove abnormal cells from the cervix) in the Central Denmark Region
Women aged 23–64 who are having a follow-up test (HPV and cell sample) 12 months after a LEEP procedure
Women aged 23–64 who have a valid cell sample (cytology) triage result on record

Who may not be able to join:

People who are recorded in the registry as having previously declined to take part in research
Women whose cell sample and HPV test results from six months after their LEEP procedure were not usable or were incomplete
Cases where there is no remaining biological sample material available for testing

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Aarhus

Registry

ClinicalTrials.gov

Start date

27 February 2023

Est. completion

1 February 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

The number of women with CIN2+ diagnosed in either cervical biopsies or cone biopsy; The number of women with CIN2+ diagnosed in either cervical biopsies or cone biopsy; The number of women with CIN3+ diagnosed in either cervical biopsies or cone biopsy; The number of women with CIN3+ diagnosed in either cervical biopsies or cone biopsy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov